Additionally, because NRP2 promotes PDGFbb and TGFβ-induced VSMC migration, proliferation, and loss of SMC contractility, it may be beneficial to inhibit NRP2 as a therapeutic strategy to treat occlusive vascular diseases. This evidence concerns the gene NRP2 and Peripheral arterial stenosis.